UNITED THERAPEUTICS Corp - Common Stock (UTHR)
CUSIP: 91307C102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,833,193
- Total 13F shares
- 43,520,361
- Share change
- -2,047,296
- Total reported value
- $15,594,079,368
- Put/Call ratio
- 152%
- Price per share
- $358.35
- Number of holders
- 617
- Value change
- -$719,584,018
- Number of buys
- 302
- Number of sells
- 267
Quarterly Holders Quick Answers
What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 91307C102:
Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
13%
|
5,469,014
|
$1,742,154,410 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
4,418,963
|
$1,407,660,664 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.7%
|
3,285,289
|
$1,046,528,812 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.7%
|
2,858,888
|
$910,698,772 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.4%
|
2,294,233
|
$730,827,922 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5.1%
|
2,174,692
|
$692,748,137 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
3.8%
|
1,625,605
|
$517,836,472 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,048,449
|
$333,574,123 | — | 30 Jun 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
2.3%
|
966,370
|
$307,837,000 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
806,988
|
$257,066,272 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
1.8%
|
763,624
|
$243,252,293 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
719,510
|
$229,199,910 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
585,969
|
$186,655,550 | — | 30 Jun 2024 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
1.3%
|
574,976
|
$183,158,477 | — | 30 Jun 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
1.3%
|
561,834
|
$178,972,221 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
539,617
|
$171,894,995 | — | 30 Jun 2024 | |
| Amundi |
13F
|
Individual |
1.1%
|
472,992
|
$147,119,432 | — | 30 Jun 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1%
|
438,684
|
$139,743,000 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
434,839
|
$138,518,043 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1%
|
434,514
|
$138,414,436 | — | 30 Jun 2024 | |
| Swedbank AB |
13F
|
Company |
0.99%
|
422,655
|
$134,636,750 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.96%
|
410,010
|
$130,619,114 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.91%
|
387,793
|
$123,531,460 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
362,730
|
$115,547,641 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.79%
|
337,203
|
$107,416,014 | — | 30 Jun 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.77%
|
331,621
|
$105,637,900 | — | 30 Jun 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.65%
|
276,531
|
$88,088,967 | — | 30 Jun 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.63%
|
268,516
|
$86,199,006 | — | 30 Jun 2024 | |
| ASSETMARK, INC |
13F
|
Company |
0.63%
|
267,708
|
$85,278,224 | — | 30 Jun 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.62%
|
266,914
|
$85,025,455 | — | 30 Jun 2024 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.61%
|
259,375
|
$82,623,908 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.57%
|
243,955
|
$77,711,866 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.55%
|
235,351
|
$74,971,061 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.55%
|
234,916
|
$74,833,000 | — | 30 Jun 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.54%
|
231,889
|
$73,868,000 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.53%
|
226,809
|
$72,250,007 | — | 30 Jun 2024 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.53%
|
226,655
|
$72,200,950 | — | 30 Jun 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.51%
|
220,282
|
$70,170,831 | — | 30 Jun 2024 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
0.44%
|
189,180
|
$60,263,289 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.44%
|
188,862
|
$60,161,990 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.43%
|
183,897
|
$58,580,390 | — | 30 Jun 2024 | |
| Clark Capital Management Group, Inc. |
13F
|
Company |
0.41%
|
175,913
|
$56,037,086 | — | 30 Jun 2024 | |
| Eagle Health Investments LP |
13F
|
Company |
0.39%
|
167,499
|
$53,356,806 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.38%
|
162,256
|
$51,686,649 | — | 30 Jun 2024 | |
| COMERICA BANK |
13F
|
Company |
0.38%
|
160,865
|
$51,243,515 | — | 30 Jun 2024 | |
| KBC Group NV |
13F
|
Company |
0.37%
|
158,341
|
$50,440,000 | — | 30 Jun 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.37%
|
157,156
|
$50,062,044 | — | 30 Jun 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.36%
|
155,525
|
$49,542,000 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.36%
|
153,220
|
$48,808,231 | — | 30 Jun 2024 | |
| Polaris Capital Management, LLC |
13F
|
Company |
0.35%
|
148,550
|
$47,320,603 | — | 30 Jun 2024 |
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2024
As of 30 Sep 2024,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
617 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,520,361 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, LSV ASSET MANAGEMENT, and AQR CAPITAL MANAGEMENT LLC.
This page lists
619
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
557
Q3 2024 holders
617
Holder diff
60
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.